Pharmacokinetics, pharmacodynamics, and safety of prandial oral insulin (N11005) in healthy subjects

AIMS: To verify whether the oral insulin N11005 is administered as a prandial insulin by assessing the pharmacokinetics (PK), pharmacodynamics (PD), and safety profiles of N11005 with a short-acting biosynthetic human insulin (Novolin R) as reference. METHODS: This was a randomized, open-label, sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qi, Wang, Xiaoxia, Li, Wenjia, Chen, Xiaofeng, Zhuang, Yulei, Zhou, Qinghong, Huang, Yuhui, Zhou, Yijie, Lan, Li, Wang, Zhijie, Wang, Wenjia, Hong, Juan, Hao, Wei-Hua, Yang, Yu-Tsai, Guo, Lixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411801/
https://www.ncbi.nlm.nih.gov/pubmed/37564986
http://dx.doi.org/10.3389/fendo.2023.1172327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411801/
https://www.ncbi.nlm.nih.gov/pubmed/37564986
http://dx.doi.org/10.3389/fendo.2023.1172327

Ejemplares similares